MedMira Inc.
MMIRF
$0.0131
-$0.0769-85.44%
| Weiss Ratings | MMIRF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | E | |||
| Rating Factors | MMIRF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Very Weak | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Weak | |||
| Total Return Index | Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | MMIRF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 4.55 | |||
| Price History | MMIRF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -85.44% | |||
| 30-Day Total Return | -84.53% | |||
| 60-Day Total Return | -76.18% | |||
| 90-Day Total Return | -77.22% | |||
| Year to Date Total Return | 0.00% | |||
| 1-Year Total Return | -78.73% | |||
| 2-Year Total Return | -93.11% | |||
| 3-Year Total Return | -85.52% | |||
| 5-Year Total Return | 9.17% | |||
| 52-Week High % Change | -85.46% | |||
| 52-Week Low % Change | 0.77% | |||
| Price | MMIRF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $0.09 | |||
| 52-Week Low Price | $0.01 | |||
| 52-Week Low Price (Date) | Jun 12, 2024 | |||
| 52-Week High Price (Date) | Feb 03, 2025 | |||
| Valuation | MMIRF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 48.79M | |||
| Enterprise Value | 58.87M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | 0.00 | |||
| Earnings Per Share Growth | 21.62% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 43.67 | |||
| Price/Book (Q) | -0.66 | |||
| Enterprise Value/Revenue (TTM) | 224.18 | |||
| Price | $0.01 | |||
| Enterprise Value/EBITDA (TTM) | -28.32 | |||
| Enterprise Value/EBIT | -26.43 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | MMIRF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 701.73M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | MMIRF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 902 450 1588 | |||
| Address | 155 Chain Lake Drive Halifax, NS B3S 1B3 | |||
| Website | medmira.com | |||
| Country | Canada | |||
| Year Founded | 1993 | |||
| Profitability | MMIRF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -848.30% | |||
| Profit Margin | -1,075.46% | |||
| Management Effectiveness | MMIRF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -40.43% | |||
| Return on Equity | -- | |||
| Income Statement | MMIRF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 262.50K | |||
| Total Revenue (TTM) | 262.50K | |||
| Revenue Per Share | $0.00 | |||
| Gross Profit (TTM) | -486.70K | |||
| EBITDA (TTM) | -2.08M | |||
| EBIT (TTM) | -2.23M | |||
| Net Income (TTM) | -2.82M | |||
| Net Income Avl. to Common (TTM) | -2.82M | |||
| Total Revenue Growth (Q YOY) | -47.93% | |||
| Earnings Growth (Q YOY) | -65.77% | |||
| EPS Diluted (TTM) | 0.00 | |||
| EPS Diluted Growth (Q YOY) | -87.50% | |||
| Balance Sheet | MMIRF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 757.50K | |||
| Cash Per Share (Q) | $0.00 | |||
| Total Current Assets (Q) | 1.92M | |||
| Total Preferred Equity (Q) | 0.00 | |||
| Total Equity (Q) | -13.88M | |||
| Current Ratio (Q) | 0.125 | |||
| Book Value Per Share (Q) | -$0.02 | |||
| Total Assets (Q) | 3.58M | |||
| Total Current Liabilities (Q) | 15.32M | |||
| Total Debt (Q) | 11.16M | |||
| Total Liabilities (Q) | 17.46M | |||
| Total Common Equity (Q) | -13.88M | |||
| Cash Flow | MMIRF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -543.20K | |||
| Cash from Financing (TTM) | 3.06M | |||
| Net Change in Cash (TTM) | 130.60K | |||
| Levered Free Cash Flow (TTM) | -3.75M | |||
| Cash from Operations (TTM) | -2.39M | |||
